StockData
Rallybio Corp logo

Rallybio Corp (RLYB) stock

RLYBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/30
$15.26−0.03 (-0.20%)

Close on Nov 18, 2026Market cap $82.16MP/E 3.3Yield –

Rallybio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Rallybio's price to book ratio was 0.9× on Nov 11, 2026, against 0.4× a year earlier. Over the last 5 years it ranged from 0.2× to 3.1×, with a median of 0.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.9×+0.4
2025Dec 31, 20250.5×−0.1
2024Dec 31, 20240.6×−0.2
2023Dec 29, 20230.7×−0.9
2022Dec 30, 20221.6×−0.0
2021Dec 31, 20211.6×–

More Rallybio figures

See a number that looks wrong?